Navigation Links
Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Date:10/25/2012

SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the third quarter of fiscal 2012 on Tuesday, November 6.

The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time (5 p.m., Eastern Standard Time), Tuesday, November 6, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer.

The teleconference can be accessed by calling (631) 291-4555, passcode 40234244. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available through the company's website at www.volcanocorp.com.

A replay of the conference call will be available through Tuesday, November 13, at (404) 537-3406, passcode 40234244, and via the company's website.

About Volcano Corporation

Volcano Corporation (NASDAQ: VOLC) is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using sound and light as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at w
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
2. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
3. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
4. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
5. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
6. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
7. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
8. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
9. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
10. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
11. Unilife Corporation To Announce Financial Results For Fiscal 2013 First Quarter On Tuesday, October 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Calif. , May 23, 2013 More ... cancer may not benefit from chemotherapy and still have ... the launch of one of the largest sources of ... new website and interactive Facebook page provide recently diagnosed ... they can safely avoid chemotherapy. "We anticipate ...
(Date:5/23/2013)... May 23, 2013  Every day, their baby stopped breathing, ... his lungs. April and Bryan Gionfriddo ... true. "Quite a few doctors said he had ... April Gionfriddo , about her now 20-month-old ... would work, we would take it and run with it." ...
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... in Blood Glucose,Control and Progressive Weight Loss ... Amylin,Pharmaceuticals, Inc. and Eli Lilly and Company ... BYETTA(R) (exenatide) injection,sustained improvements in blood sugar ... a half years of therapy. BYETTA treatment,was ...
... --,Phosphagenics Limited (AIM: PSG) announced today positive results,from ... formulated with retinoic acid, a leading topical,treatment for ... cosmetics. , The proof of concept studies showed ... delivered into the skin when formulated,with TPM-02 compared ...
Cached Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Phosphagenics Announces Positive Proof of Concept Results from,Studies Utilizing Company's Dermal Drug Delivery Technology 2
(Date:5/23/2013)... Jackson, TN (PRWEB) May 23, 2013 Spring ... fit, but what’s gotten into Jackson , the city ... variety of new fitness facilities and wellness centers has transformed ... in the state. , “In any city of vibrant, ... to improve or promote health,” said Kim White, owner of ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Parker ... the rights of victims injured by defective medical devices ... Counsel Matthew J. McCauley has been appointed Co-Lead Counsel ... Mirena IUD Products Liability Litigation (Case 7:13-md-02434-CS). The Order, ... and Liaison Counsel are to submit their proposal for ...
(Date:5/23/2013)... (HealthDay News) -- The sensation of itching is hardwired ... to a small molecule released in the spinal cord, ... Researchers say this molecule, known as natriuretic polypeptide b ... nervous system. Ultimately, this signal is experienced as an ... are similar, the researchers concluded that a similar process ...
(Date:5/23/2013)... A shortage of a critical tuberculosis drug has hampered ... to contain the spread of the highly infectious lung ... was first used in 1951 and is one of ... first-line treatment for tuberculosis (TB). Patients must take the ... U.S. Centers for Disease Control and Prevention. However, ...
(Date:5/23/2013)... is available in French . ... discovered a novel molecular mechanism that can potentially slow ... abnormal growth. In the May 23 edition of the ... of Montreal explain how they found that the anti-cancer ... from dividing. , "Cells normally monitor the availability of ...
Breaking Medicine News(10 mins):Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Shortage of Key Drug Hampering U.S. Efforts to Control TB: Report 2Health News:Scientists discover how rapamycin slows cell growth 2
... from UK show that proteins secreted by eggs of the ... the next anti-inflammatory therapy // . ,Their study ... Experimental Medicine. ,Schistosoma mansoni, a trematode parasite that ... the host to tolerate chronic worm infections, often for decades, ...
... many different forms of cancer. Smoking is linked to many ... For example, 1/3rd of all bladder cancers are caused due ... the scientific community to sensitize individuals to the ill effects ... ,A new study conducted on cancer patients has ...
... been widely talked about and largely accepted. In the same ... there is a 15% reduction in the risk of heart ... of three months. , ,The sample size was 212 ... disease were put to eat a Mediterranean diet for three ...
... having IVF treatment subject themselves to more risks and complications ... fertilization (IVF) has been very successful in women who are ... the procedure a donated egg and a sperm is fertilized ... the womb of a woman. The egg can sometimes be ...
... due to Peanut allergy after her boyfriend kissed her after ... city of Saguenay, though she received a dose of adrenaline ... the hypersensitivity reaction and died a week after the kiss. ... an autopsy has been planned for Christina Desforges. , ...
... The Scientific Advisory Committee for Nutrition in United Kingdom ... acid/Vitamin B12.// , Folic acid acts as an ... women has it protects newborn babies from birth defects. ... people as they are prone to B12 deficiency leading ...
Cached Medicine News:Health News:Most Smokers Continue To Smoke Despite Developing Cancer 2Health News:Complication More in Women Having IVF Treatment 2
... Merocel Ophthalmic Products ... superior fiber free products ... and safe cleaning of ... exclusive Merocel material is ...
Merocel Ophthalmic Products provide the surgeon with fiber free products for fluid,control and safe cleaning of fine microsurgical instruments. The exclusive Merocel,material is highly absorbent,...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Medicine Products: